Repurposed drugs for COVID-19: threshold and proof requirements for trials

Detalles Bibliográficos
Autores principales: Paul, Mical, Kalil, Andre C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425289/
https://www.ncbi.nlm.nih.gov/pubmed/34508887
http://dx.doi.org/10.1016/j.cmi.2021.08.024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425289/
https://www.ncbi.nlm.nih.gov/pubmed/34508887
http://dx.doi.org/10.1016/j.cmi.2021.08.024

Ejemplares similares